HomeTelaprevirTelaprevir + Rapamycin

Does Telaprevir Interact with Rapamycin?

Telaprevir and Rapamycin have a contraindicated drug interaction according to U.S. FDA drug labeling data. Protease inhibitor and strong CYP3A4/P-gp inhibitor that increases sirolimus concentrations. Avoid concomitant use. The mechanism involves cyp3a4 and p-gp inhibition. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Contraindicated
Rapamycin Class
mTOR Inhibitor Immunosuppressant
Management
Do not take together
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Telaprevir and Rapamycin occurs because cyp3a4 and p-gp inhibition. Clinically, this means protease inhibitor and strong cyp3a4/p-gp inhibitor that increases sirolimus concentrations. avoid concomitant use. Because of the severity of this interaction, these medications are contraindicated — meaning they should not be taken together under any circumstances. If you are currently taking both, contact your healthcare provider immediately to discuss alternatives.

What To Tell Your Doctor or Pharmacist

If you are taking Telaprevir and your doctor is considering prescribing Rapamycin (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask about alternative medications that do not interact with your current regimen
  • Ask how frequently you should be monitored while these are co-prescribed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Telaprevir+💊 Rapamycin

Severity & Interaction Details

contraindicated
Avoid this combination
FDA labeling lists this pair as contraindicated. The risk outweighs the benefit in nearly all cases.
Severity scale
MinorContra
On record
Yes
Drug A class
Drug B class
mTOR Inhibitor Immunosuppressant
Source
NLP:sirolimus

What this means in plain English

Protease inhibitor and strong CYP3A4/P-gp inhibitor that increases sirolimus concentrations. Avoid concomitant use.

What the FDA label says

"CYP3A4 and P-gp inhibition"

📖 Source: NLP:sirolimus

Recent research & FDA safety updates

Live

Auto-aggregated from PubMed E-utilities and FDA safety data.

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Telaprevir and Rapamycin against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.